Damien JOLLY
Reims, France
NCT Number: NCT03320798
Bullous pemphigoid affects mainly elderly patients. It is often associated with neurologic disorders, which represent a major risk factor of the disease
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Reims, France
The aim was to determine whether neurologic disorders, especially dementia, influences outcome and mortality of patients with bullous pemphigoid.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: Day 0
neurological disease are dementia (Alzheimers disease or other dementia), Parkinson's syndrome and stroke. Diagnosis of dementia was carried out in several ways: after examination by a neurologist or geriatrician, when the Mini Mental State was less than or equal to 17 or in the presence of a demonstrated and clinically evident dementia.
CHU de Reims
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04206553
Autoimmune Diseases, Bullous Pemphigoid
Birmingham, Alabama, United States
View Trial DetailsNCT03926377
Autoimmune Diseases, Bone Diseases
Amiens, France
View Trial DetailsNCT02313870
Autoimmune Diseases, Bullous Pemphigoid
Montpellier, France
View Trial DetailsNCT00525616
Autoimmune Diseases, Bullous Pemphigoid
Rouen, France
View Trial Details